These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4857262)

  • 41. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer.
    Heracek J; Hampl R; Hill M; Starka L; Sachova J; Kuncova J; Eis V; Urban M; Mandys V
    Steroids; 2007 Apr; 72(4):375-80. PubMed ID: 17368496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.
    Titus MA; Schell MJ; Lih FB; Tomer KB; Mohler JL
    Clin Cancer Res; 2005 Jul; 11(13):4653-7. PubMed ID: 16000557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Re: Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
    Danby FW
    J Natl Cancer Inst; 2008 Oct; 100(19):1412-3. PubMed ID: 18812556
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
    Simanainen U; McNamara K; Gao YR; Handelsman DJ
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Receptor proteins for androgen in hamster sebaceous glands.
    Adachi K
    J Invest Dermatol; 1974 Mar; 62(3):217-23. PubMed ID: 4361986
    [No Abstract]   [Full Text] [Related]  

  • 48. Androgen dynamics in vitro in the normal and hyperplastic human prostate gland.
    Giorgi EP; Stewart JC; Grant JK; Scott R
    Biochem J; 1971 Jun; 123(1):41-55. PubMed ID: 4108500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benign hyperplasia of the human prostate exposed to steroid hormones in organ culture.
    Harbitz TB; Falkanger B; Sander S
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():89-93. PubMed ID: 4141577
    [No Abstract]   [Full Text] [Related]  

  • 50. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer.
    Stanbrough M; Bubley GJ; Ross K; Golub TR; Rubin MA; Penning TM; Febbo PG; Balk SP
    Cancer Res; 2006 Mar; 66(5):2815-25. PubMed ID: 16510604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro perfusion of the canine prostate.
    Resnick MI; Walvoord DJ; Grayhack JT
    Invest Urol; 1975 Jul; 13(1):52-9. PubMed ID: 1140919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential test systems for chemotherapeutic agents against prostatic cancer.
    Sandberg AA
    Vitam Horm; 1975; 33():155-88. PubMed ID: 820067
    [No Abstract]   [Full Text] [Related]  

  • 53. Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the Gleason score.
    Nishiyama T; Ikarashi T; Hashimoto Y; Suzuki K; Takahashi K
    J Urol; 2006 Oct; 176(4 Pt 1):1387-91. PubMed ID: 16952639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relevance of studies on androgen action to prostatic cancer.
    Mainwaring WI
    Curr Top Mol Endocrinol; 1976; 4():152-71. PubMed ID: 800357
    [No Abstract]   [Full Text] [Related]  

  • 55. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
    Humphries JE; Isaacs JT
    Cancer Res; 1982 Aug; 42(8):3148-56. PubMed ID: 7093958
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antagonistic action of anti-androgens on the formation of a specific dihydrotestosterone-receptor protein complex in rat ventral prostate.
    Fang S; Liao S
    Mol Pharmacol; 1969 Jul; 5(4):428-31. PubMed ID: 5816873
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparative effects and mechanisms of castration, estrogen anti-androgen, and anti-estrogen-induced regression of accessory sex organ epithelium and muscle.
    Neubauer B; Blume C; Cricco R; Greiner J; Mawhinney M
    Invest Urol; 1981 Jan; 18(4):229-34. PubMed ID: 7451082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The interaction of dihydrotestosterone and oestradiol-17beta with macromolecules in human hyperplastic prostate tissue.
    Fraser HM; Mitchell AJ; Anderson CK; Oakey RE
    Acta Endocrinol (Copenh); 1974 Aug; 76(4):773-82. PubMed ID: 4135747
    [No Abstract]   [Full Text] [Related]  

  • 59. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New concepts on the androgen sensitivity of prostate cancer.
    Labrie F; Luthy I; Veilleux R; Simard J; Bélanger A; Dupont A
    Prog Clin Biol Res; 1987; 243A():145-72. PubMed ID: 3309970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.